Does the United States Need to Strengthen the System of Care for Infectious Diseases?

Abstract

The views, opinions, and/or findings contained in this report are those of The MITRE Corporation and RAND Corporation and should not be construed as official government position, policy, or decision unless so designated by other documentation. Limited Print and Electronic Distribution RightsThis document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized online posting of this content is prohibited. Permission is given to duplicate this document for personal use only, as long as it is unaltered and complete. Permission is required from RAND to reproduce, or reuse in another form, the information in this research document for commercial use. For information on reprint and linking permissions, please visit www.rand.org/pubs/permissions.html.The RAND Corporation is a research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous. RAND is nonprofit, nonpartisan, and committed to the public interest. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.The MITRE Corporation is a not-for-profit company that operates multiple federally funded research and development centers (FFRDCs). MITRE provides innovative, practical solutions for some of our nation's most critical challenges in defense and intelligence, aviation, civil systems, homeland security, the judiciary, and healthcare. www.rand.org www.mitre.orgFor more information on this publication, visit www.rand.org/t/rr2046.

SHEA statement on antibiotic stewardship in hospitals during public health emergencies

“…8 The pandemic has reinforced prior analyses, which identified numerous vulnerabilities, including inconsistent funding for US public health preparedness and response that contributed to inadequate resources for treatment, testing, and contact tracing, and breakdowns in the supply chain for essential healthcare equipment. [9][10][11] As a new disease, COVID-19 led to rapidly evolving information, particularly early in the pandemic. Patients with COVID-19 can present with severe illness and clinical and laboratory findings suggestive of bacterial coinfection.…”